Haemonetics Stock Market Value
| HAE Stock | USD 81.24 2.22 2.66% |
| Symbol | Haemonetics |
Haemonetics Price To Book Ratio
Is Haemonetics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Haemonetics. If investors know Haemonetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Haemonetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.05) | Earnings Share 2.46 | Revenue Per Share 25.092 | Quarterly Revenue Growth 0.101 | Return On Assets 0.0612 |
The market value of Haemonetics is measured differently than its book value, which is the value of Haemonetics that is recorded on the company's balance sheet. Investors also form their own opinion of Haemonetics' value that differs from its market value or its book value, called intrinsic value, which is Haemonetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Haemonetics' market value can be influenced by many factors that don't directly affect Haemonetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Haemonetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Haemonetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Haemonetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Haemonetics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Haemonetics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Haemonetics.
| 03/20/2024 |
| 04/19/2024 |
If you would invest 0.00 in Haemonetics on March 20, 2024 and sell it all today you would earn a total of 0.00 from holding Haemonetics or generate 0.0% return on investment in Haemonetics over 30 days. Haemonetics is related to or competes with Agilent Technologies, Illumina, Waters, Thermo Fisher, Mettler Toledo, Charles River, and Guardant Health. Haemonetics Corporation, a healthcare company, provides medical products and solutions More
Haemonetics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Haemonetics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Haemonetics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.9 | |||
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 7.29 | |||
| Value At Risk | (2.52) | |||
| Potential Upside | 2.39 |
Haemonetics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Haemonetics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Haemonetics' standard deviation. In reality, there are many statistical measures that can use Haemonetics historical prices to predict the future Haemonetics' volatility.| Risk Adjusted Performance | 0.0167 | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | (0.14) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | 0.0142 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Haemonetics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Haemonetics Backtested Returns
Haemonetics holds Efficiency (Sharpe) Ratio of -0.0053, which attests that the entity had a -0.0053% return per unit of risk over the last 3 months. Haemonetics exposes twenty-eight different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Haemonetics' Market Risk Adjusted Performance of 0.0242, downside deviation of 1.9, and Risk Adjusted Performance of 0.0167 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 1.3, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Haemonetics will likely underperform. Haemonetics has an expected return of -0.0093%. Please make sure to check out Haemonetics downside deviation, total risk alpha, value at risk, as well as the relationship between the information ratio and treynor ratio , to decide if Haemonetics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.24 |
Weak reverse predictability
Haemonetics has weak reverse predictability. Overlapping area represents the amount of predictability between Haemonetics time series from 20th of March 2024 to 4th of April 2024 and 4th of April 2024 to 19th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Haemonetics price movement. The serial correlation of -0.24 indicates that over 24.0% of current Haemonetics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.24 | |
| Spearman Rank Test | -0.55 | |
| Residual Average | 0.0 | |
| Price Variance | 0.98 |
Haemonetics lagged returns against current returns
Autocorrelation, which is Haemonetics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Haemonetics' stock expected returns. We can calculate the autocorrelation of Haemonetics returns to help us make a trade decision. For example, suppose you find that Haemonetics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Haemonetics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Haemonetics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Haemonetics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Haemonetics stock over time.
Current vs Lagged Prices |
| Timeline |
Haemonetics Lagged Returns
When evaluating Haemonetics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Haemonetics stock have on its future price. Haemonetics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Haemonetics autocorrelation shows the relationship between Haemonetics stock current value and its past values and can show if there is a momentum factor associated with investing in Haemonetics.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Haemonetics Correlation, Haemonetics Volatility and Haemonetics Alpha and Beta module to complement your research on Haemonetics. For information on how to trade Haemonetics Stock refer to our How to Trade Haemonetics Stock guide.Note that the Haemonetics information on this page should be used as a complementary analysis to other Haemonetics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Complementary Tools for Haemonetics Stock analysis
When running Haemonetics' price analysis, check to measure Haemonetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Haemonetics is operating at the current time. Most of Haemonetics' value examination focuses on studying past and present price action to predict the probability of Haemonetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Haemonetics' price. Additionally, you may evaluate how the addition of Haemonetics to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
Haemonetics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.